Next Article in Journal
Cystic Echinococcosis in Hospitalized Children and Adults from Western Romania: 2007–2022
Next Article in Special Issue
Comparative Assessment of Rapid Identification and Antimicrobial Susceptibility Testing Methods for Bloodstream Infections in a Non-24/7 Clinical Microbiology Laboratory
Previous Article in Journal
Immunoinformatics Predictions on Variable Mycobacterium tuberculosis Lineage 6 T Cell Epitopes and HLA Interactions in West Africa
Previous Article in Special Issue
A Bioluminescence-Based Serum Bactericidal Assay to Detect Bactericidal Antibodies Against Neisseria meningitidis in Human Sera
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review

by
Patricia A. Meza-Meneses
1,
Rodrigo Pérez Becerra
2,
Gerardo Garza Sainz
2,
Luis Trujillo Ortiz
2,
Adrián Martinez Correa
2,
Alan Rodrigo Pérez Soriano
2,
Ruben Miguel Angel Santiago González
2,
Aarón Delgado Corral
2,
Omar Vieyra Valdez
2,
Genaro Argüelles Morales
2,
Mario Alberto Toledo Díaz
2,
Alberto Saldivar Luna
2,
Carlos Alberto Castro-Fuentes
3,* and
Victor Osornio Sánchez
2,*
1
Infectology Service, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano de Seguro Social Para el Bienestar (IMSS-BIENESTAR), Carretera Federal Mexico-Puebla Km 34.5, Ixtapaluca 56530, Mexico
2
Urology Service, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano de Seguro Social Para el Bienestar (IMSS-BIENESTAR), Carretera Federal Mexico-Puebla Km 34.5, Ixtapaluca 56530, Mexico
3
Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano de Seguro Social Para el Bienestar (IMSS-BIENESTAR), Carretera Federal Mexico-Puebla Km 34.5, Ixtapaluca 56530, Mexico
*
Authors to whom correspondence should be addressed.
Microorganisms 2025, 13(5), 1033; https://doi.org/10.3390/microorganisms13051033
Submission received: 11 March 2025 / Revised: 18 April 2025 / Accepted: 28 April 2025 / Published: 30 April 2025

Abstract

:
Urinary actinomycosis is a rare condition, often mimicking a urinary tract tumor. Due to its low prevalence, it can be challenging to diagnose and may be mistaken for malignancies. A 33-year-old female patient with a history of type 2 Diabetes Mellitus and recurrent urinary tract infections presented to the emergency room with right renal fossa pain radiating to the right hypochondrium, fever with chills, nausea, and vomiting. Physical examination revealed a positive Giordano sign and tenderness at the ipsilateral middle and upper ureteral points. A contrast-enhanced CT scan showed a mass infiltrating the distal third of the right ureter, causing retrograde dilatation and hydronephrosis. Additionally, a liver injury with both liquid and solid components was observed. Therefore, given the suspicion of a urothelial tumor, a diagnostic cystoscopy and ureteroscopy were performed. Using interventional radiology, an abscessed liver lesion was drained, yielding purulent fluid. The histopathological examination revealed no evidence of malignancy. However, due to the strong suspicion of upper urinary tract urothelial carcinoma, a right radical nephroureterectomy with bladder cuff excision and retroperitoneal lymphadenectomy was performed. Histopathological examination ultimately confirmed urinary actinomycosis. Consequently, antibiotic therapy with oral amoxicillin 2 g every 12 h was initiated, leading to a good clinical response. Despite its low incidence, urinary actinomycosis should be considered as a differential diagnosis in cases suspected of urothelial tumors in the upper urinary tract. Increased awareness of this rare condition may help prevent unnecessary surgical interventions.

1. Introduction

The genus Actinomyces belongs to the Actinobacteria phylum and Actinomycetales order and is comprised of anaerobic, Gram-positive, commensal bacteria found in the skin, oral cavity, gastrointestinal tract, and female genital tract [1]. To date, 25 species of Actinomyces have been described; of these, A. israelii, A. gerencseriae, A. odontolyticus, A. meyeri, A. naelundii, A. viscosus, A. pyogenes, A. georgiae, and A. graevenitzii are the main etiologic agents of actinomycosis in humans [1,2].
Actinomycosis is a rare chronic bacterial infection that occurs due to the migration of Actinomyces spp. to deep tissues through trauma, procedures, or foreign bodies that disrupt the barrier formed by the mucous membranes [2]. It commonly affects the cervicofacial area, thoracic, abdominal, and pelvic regions, and even the central nervous system (CNS). Among the unusual clinical forms of human actinomycosis, the involvement of the urinary tract is one of the least frequent. In this sense, A. israelii, A. turicensis, A. naeslundii, A. ontolyticus, and A. gerencseriae are the species most frequently identified in the genital tract, with few reports of A. urogenitalis and A. neuii in the amniotic fluid, as well as A. meyeri as a cause of chorioamniotitis [2]. Particularly, A. schaalii, A. turicensis, A. urogenitalis, A. neuii, and A. europaeus have been identified as etiological agents in urinary tract infections in humans [2].
Characteristic features of actinomycosis include chronic manifestations, abscess formation with sinus tracts, and purulent discharge. However, little is known about the virulence factors of Actinomyces species. However, they do not produce classical exotoxins, and their virulence is attributed to the ability to evade phagocytosis by the host immune system, to bind to collagen via fimbriae, and to develop biofilms [2,3].
At present, the prevalence of infections caused by Actinomyces species is unknown, and information in developing countries is incomplete [4] and often underdiagnosed due to their indolent nature and the difficulty in culturing the organism. In existing reports in the literature, the diagnosis of actinomycosis is based solely on clinical and histopathological findings; when present, sulfur granules can be stained with Gram stain or methylene blue and assessed by microscopy. However, granules are not specific for actinomycosis. So, on certain occasions, it can mimic other pathologies, like upper urinary tract urothelial tumor [5].
Therefore, this study aims to report a case of urinary tract actinomycosis that presented clinically as a urothelial tumor and resolved successfully. A literature review was also conducted to compile the clinical characteristics of reported cases of actinomycosis affecting the urinary tract.

2. Case Presentation

A 33-year-old female patient had a history of type 2 Diabetes Mellitus under suboptimal control and without other risk factors for immunocompromise, with a history of recurrent urinary tract infections and use of multiple outpatient antibiotic regimens in the last year before admission. The patient arrived at the emergency room with a condition characterized by pain in the right renal fossa that radiated to the right hypochondrium, fever with chills, nausea, and vomiting. Upon arrival at our hospital, the vital signs showed blood pressure of 113/64 mmHg, temperature of 38.3 °C, heart rate of 99 bpm, respiratory rate of 21 rpm, and oxygen saturation of 97% in room air. Physical examination revealed a positive Giordano’s sign and positive ipsilateral middle and upper ureteral points. Therefore, laboratory studies were requested, where it was identified as iron deficiency anemia with hemoglobin of 10.3 g/dL, leukocytes of 10,500 cells/mcl with neutrophilia of 78%, platelets of 614,000/mcl, metabolic decontrol with fasting glucose of 240 mg/dL, preserved renal function with creatinine of 0.78 mg/dL, and elevated alkaline phosphatase of 156 IU/L and gamma-glutamyl transpeptidase of 51 IU/L. Additionally, the general urine examination showed negative nitrites, erythrocytes 10–25 by field, leukocytes 5–10 by field, epithelial cells 2–5 by field, and abundant mucoid filaments, suggesting urinary tract infection. Therefore, antibiotic coverage with ceftriaxone was started after collecting blood and urine samples. Additionally, as part of the care protocol, at least two peripheral blood culture vials (10 mL) were processed. Blood cultures were performed in BD Bactec™ Plus Aerobic/F and BD Bactec™ Anaerobic/F culture vials and incubated at 35 ± 2 °C in the BD BACTECT™ Blood Culture System (Becton Dickinson, Franklin Lakes, NJ, USA). However, the etiologic agent was not successfully isolated from the blood cultures. A urine sample was cultured in 5% sheep blood agar and MacConkey agar, yielding the same results as the blood cultures. A contrast-enhanced tomographic study highlighted a tumor that infiltrated the distal third of the right ureter with retrograde dilatation, an ipsilateral kidney with hydronephrosis and pyeloureteral dilatation, and a liver lesion with a liquid and solid component (Figure 1).
Due to the suspicion of a urothelial tumor, the patient underwent diagnostic cystoscopy and ureteroscopy; during the procedure, a biopsy was taken (Figure 2). Using interventional radiology, it was decided to drain the abscessed liver tumor, obtaining purulent fluid. The drained fluid from the liver abscess was inoculated into liquid thioglycolate medium (Bioxon) and incubated for 24–48 h, then subcultured in BD Bactec™ Plus Aerobic/F and BD Bactec™ Anaerobic/F culture vials, replated, and incubated in a reducing environment; however, no isolation of Actinomyces spp. was obtained.
The patient completed 14 days of antibiotic treatment with ceftriaxone, and due to his positive progress with resolution of the systemic inflammatory response, the patient was discharged pending histopathological results.
During a follow-up visit, the histopathological examination revealed no evidence of malignancy, and given the high suspicion of urothelial cancer of the upper urinary tract, it was decided to subject the patient to a radical right nephroureterectomy with bladder cuff and retroperitoneal lymphadenectomy (Figure 3).
A few weeks later, the histopathological report of renal abscess showed filamentous bacillary structures arranged in a radial and disordered manner, deposit of eosinophilic material, and sulfide structures presumptive of Actinomyces spp. in hematoxylin-eosin staining (Figure 4), and due to the inconclusive diagnosis of malignancy, it was decided to adapt antibiotic therapy to amoxicillin at 2 g orally every 12 h for 6 months with good clinical evolution.

3. Discussion

In the present case report, we highlight a case of uncommon urinary actinomycosis, a misleading diagnosis of upper urinary tract urothelial tumor.
A search in the PubMed and Scopus databases was performed for case reports or reviews without distinction of languages over a period of 29 years (1995–2024), with the keywords “actinomycosis”, “Actinomyces”, “renal tumor”, “renal abscess”, and “Xanthogranulomatous pyelonephritis”. Table 1 compiles the 24 reported cases of actinomycosis with urinary tract involvement.
Of the total number of cases identified in the international literature, the main clinical presentation was a renal tumor; however, according to reports, it can also present as emphysematous pyelonephritis, xanthogranulomatous pyelonephritis, or even be asymptomatic. In addition to our clinical case, there is only one other report with a clinical presentation of a urothelial tumor with signs of obstruction and suspected neoplasia [13]. It is worth mentioning that clinical manifestations usually present in a subacute or chronic form. However, they have presented in a severe acute form, with the development of septic shock [19,24,26].
According to the literature, actinomycosis can occur in immunocompromised and immunocompetent patients. In the review of the reported cases, 44% (n = 11) presented some type of immunocompromise, such as Diabetes Mellitus (n = 7; 28%), pregnancy (n = 2; 8%), cancer (n = 1; 4%) and ESRD (n = 1; 4%), and Kidney stones were present in three cases (12%) as a risk factor for urinary tract infection.
Actinomycosis of the urinary tract has a good prognosis, with resolution of the infection. A total of 68% (n = 17) of patients underwent nephrectomy for the treatment of actinomycosis, and only 24% (n = 6) achieved resolution with antibiotic treatment or abscess drainage; only one patient died [26]. However, the patient suffered from various uncontrolled comorbidities and severe hyperkalemia that led to cardiac arrest.
The imaging findings of renal actinomycosis have been extrapolated from abdominopelvic actinomycosis, characterized by heterogeneous infiltrating solid and/or cystic masses that enhance with contrast medium. These findings are not different from renal masses from other etiologies, such as neoplastic [30,31]. The aggressive nature of this infiltration is the telltale clue to actinomycosis, as it is known for its ability to spread contiguously across tissue planes. In the cases found in the databases, 40% (n = 10) showed involvement of other tissues, including the duodenum, psoas muscle, liver, colon, lung, and diaphragm. Because Actinomyces species generally do not spread lymphatically due to the size of the organism, actinomycosis is rarely associated with regional lymphadenopathy. Thus, to distinguish actinomycosis from malignancy, the diagnosis of actinomycosis should be considered if a highly infiltrative contrast-enhancing mass is observed, accompanied by none or a few reactive regional lymph nodes [30]. In the cases reported in the literature, no involvement of the lymph nodes has been observed.
Currently, ureteroscopic biopsy is the most accurate method for the histological evaluation of oncological and non-oncological pathologies of the upper urinary tract. This technique can be used to diagnose urinary tract urothelial carcinoma (UTUC), and in some cases, staging can be established. However, in some cases, when the sample size is small, it is insufficient for an accurate diagnosis, or the sample is lost during processing [32].
Regarding the most commonly used ureteroscopy devices, these are baskets and forceps. In the diagnosis of urothelial carcinoma of the urinary tract, the use of a basket allows for successful cytopathological diagnosis in 94% of cases, compared to only 63% with forceps. For large tumors (≥10 mm), basket biopsy remains superior, providing a diagnosis in 94% of cases, compared to 80% with forceps [33].
In cases where ureteroscopic biopsy is inconclusive of malignancy, the origin of the disease should be suspected based on imaging studies and clinical course. Because there are no reports in the literature on the diagnostic accuracy of ureteroscopic biopsy specifically for the diagnosis of Actinomyces sp. [34].
The definitive diagnosis of actinomycosis requires a combination of histopathological, microbiological, and molecular studies.
In the cases reported to date, according to the primary data, the diagnosis was made by histopathological examination in 84% (n = 21). The presence of branching gram-positive bacilli should raise suspicion of actinomycosis; it is distinguished from other branching gram-positive bacilli, such as Nocardia spp., by its non-acid-fast nature [35]. Although in histopathological analysis, when present, sulfur granules can be stained with Gram stain or methylene blue and evaluated by microscopy; however, the granules are not specific for actinomycosis. Most reported cases of actinomycosis have been confirmed by histopathological examination, where the actinomycotic granuloma containing fibroblasts, plasma cells, giant cells, and polymorphonuclear cells is observed. In the present case report, the identification of the causative agent could only be performed at the genus level through the structures observed in the histopathological study, and because it was not possible to isolate the microorganism in a culture medium, identification at the species level was not possible.
Isolation of Actinomyces species in cultures was only reported in 20% (n = 5) of the cases found in the international literature, being caused by A. israelii (40%), A. gerencseriae (20%), A. meyeri (20%), and A. odontolyticus (20%). Hematogenous dissemination of actinomycosis has been reported to be rare in the reported cases, there was only one isolation of Actinomyces spp. in blood [22]. In the literature, it has been described that actinomycosis infections are polymicrobial in nature, but only two cases presented this characteristic with additional isolation of Actinobacillus actinomycetemycomitans [10] and Proteus mirabilis [29]. Perhaps the use of previous antibiotics for urinary tract infections is the cause of polymicrobial infections.
Actinomyces spp. are slow-growing microaerophilic bacteria, requiring prolonged anaerobic incubation of cultures for up to 20 days. However, the success rate in obtaining the etiological agent is low. Whereas, in cases where a positive culture is obtained, mass spectrometry such as matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) can correctly identify up to 97% of isolates to the species level [3]. Alternative methods, such as 16S rRNA gene sequence analysis, have allowed the identification of Actinomyces spp. in clinical samples through the construction of phylogenetic relationships [36]. Furthermore, commercial kits with universal primers that amplify all members of the Bacteria domain are currently available [37].
Most Actinomyces species are susceptible to penicillin and other beta-lactams, and some are intrinsically resistant to metronidazole [38]. The literature reports that they may also be susceptible to cephalosporins, clindamycin, carbapenems, and tetracyclines; doxycycline [39] can be used as an alternative for patients allergic to penicillin. A total of 64% (n = 16) of cases reported in the literature were treated with some type of penicillin—benzylpenicillin, amoxicillin, or piperacillin.
Particularly, A. europaeus and A. turicensis are the species with the highest resistance to some antibiotics [39]. A. turicensis is resistant to clindamycin, tetracyclines (doxycycline and tetracycline), macrolides (clarithromycin and erythromycin), ciprofloxacin, and linezolid. Meanwhile, A. europeaus has shown resistance to ceftriaxone, clindamycin, macrolides (clarithromycin and erythromycin), ciprofloxacin, and tazobactam [39]. While an increase in the Minimum Inhibitory Concentration (MIC) values has been observed for A. funkei (tetracycline), A. graevenitzii (doxycycline and tetracycline), A. israelii (linezolid), A. odontolyticus (clindamycin), and A. viscosus (clindamycin) [40].
There are no treatment guidelines specifying the preferred duration or route of administration (oral or intravenous) for actinomycosis. Therefore, treatment should be individualized and usually prolonged, 6 to 12 months, until the infectious process is resolved. It is worth mentioning that abscess treatment requires drainage, while resective surgery may be performed in cases with extensive necrotic lesions or situations of antimicrobial therapy failure [2].
To our knowledge, this would be the 25th case report of actinomycosis with urinary tract involvement reported worldwide. Cases identified in the literature describe the potential for treating urinary actinomycosis with conservative management (antibiotics and abscess drainage) with good results [7,8,10,12,21,24], before considering more invasive interventions such as partial or radical nephrectomy. As in our case, the potential for misdiagnosis of urothelial cancer led to the decision to perform radical nephrectomy. Although good clinical outcomes are also reported for patients undergoing partial or radical nephrectomy in the reported cases, no case reported on the development of any potential long-term complications from this surgical procedure, such as the risk of developing chronic kidney disease, hypertension, or cardiovascular disease.
Among the limitations of this study are its retrospective nature, in which information on some cases is incomplete, and the description of imaging studies is inconsistent. By collecting only cases reported in the literature, these may not represent the entire population affected by urinary actinomycosis.

4. Conclusions

Due to the low growth success rate of Actinomyces spp. in culture media, histopathology represents a highly useful tool in the diagnosis of actinomycosis. Although the etiologic agent of Actinomyces was not identified at the species level in this case report, a favorable outcome was achieved with treatment with amoxicillin.
Actinomycosis can occur in patients with various risk factors, including DM, pregnancy, cancer, and ESRD. Kidney stones, on the other hand, are not the main predisposing factor for actinomycosis.
Differential diagnoses are necessary when urinary tract tumor masses are identified. Therefore, early and accurate diagnosis is crucial to avoid unnecessary surgical procedures and to initiate appropriate antimicrobial therapy.

Author Contributions

Conceptualization, P.A.M.-M., C.A.C.-F. and V.O.S.; methodology, P.A.M.-M., R.P.B., G.G.S., L.T.O., A.M.C., A.R.P.S., R.M.A.S.G., A.D.C., O.V.V., G.A.M., M.A.T.D., A.S.L., V.O.S. and C.A.C.-F.; investigation, P.A.M.-M. and C.A.C.-F.; writing—original draft preparation, P.A.M.-M., C.A.C.-F. and V.O.S.; writing—review and editing, P.A.M.-M., C.A.C.-F. and V.O.S.; supervision, C.A.C.-F. and V.O.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was approved by the Ethics Committee on the Investigation of Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), a dependency of the health services of the Instituto Mexicano del Seguro Social para el Bienestar, with approval number: NR-054-2024 (13 November 2024).

Informed Consent Statement

Informed consent was obtained from the patients for this study.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding authors.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Valour, F.; Karsenty, J.; Breton, P.; Gleizal, A.; Braun, E.; Chidiac, C.; Ader, F.; Senechal, A.; Dupieux, C.; Lustig, S.; et al. Actinomycosis: Etiology, Clinical Features, Diagnosis, Treatment, and Management. Infect. Drug Resist. 2014, 7, 183. [Google Scholar] [CrossRef] [PubMed]
  2. Könönen, E.; Wade, W.G. Actinomyces and related organisms in human infections. Clin. Microbiol. Rev. 2015, 28, 419–442. [Google Scholar] [CrossRef]
  3. Boyanova, L.; Kolarov, R.; Mateva, L.; Markovska, R.; Mitov, I. Actinomycosis: A frequently forgotten disease. Future Microbiol. 2015, 10, 613–628. [Google Scholar] [CrossRef] [PubMed]
  4. Wong, V.K.; Turmezei, T.D.; Weston, V.C. Actinomycosis. BMJ 2011, 343, d6099. [Google Scholar] [CrossRef] [PubMed]
  5. Najib, B.; Arab, W.; Khazen, J.; Abdelkhalek, Y.; Abdallah, W.; Khaddage, A.; Atallah, D. A case of pelvic actinomycosis affecting genital, urinary and digestive tracts: A rare misleading diagnosis. Future Sci. OA 2021, 7, FSO740. [Google Scholar] [CrossRef]
  6. Cvetkov, M.C.; Elenkov, C.; Georgiev, M.; Topov, U.; Stefanova, G. Renal actinomycosis complicated by renoduodenal fistula and diabetes mellitus. Br. J. Urol. 1995, 75, 104–105. [Google Scholar] [CrossRef]
  7. Hyldgaard-Jensen, J.; SandstrØm, H.R.; Pedersen, J.F. Ultrasound diagnosis and guided biopsy in renal actinomycosis. Br. J. Radiol. 1999, 72, 510–512. [Google Scholar] [CrossRef]
  8. Horváth, K.; Porkoláb, Z.; Palkó, A. Primary renal and retroperitoneal actinomycosis. Eur. Radiol. 2000, 10, 287–289. [Google Scholar] [CrossRef]
  9. Dieckmann, K.P.; Henke, R.P.; Ovenbeck, R. Renal actinomycosis mimicking renal carcinoma. Eur. Urol. 2001, 39, 357–359. [Google Scholar] [CrossRef]
  10. Hilfiker, M.L. Disseminated actinomycosis presenting as a renal tumor with metastases. J. Pediatr. Surg. 2001, 36, 1577–1578. [Google Scholar] [CrossRef]
  11. Horino, T.; Yamamoto, M.; Morita, M.; Takao, T.; Yamamoto, Y.; Geshi, T. Renal Actinomycosis Mimicking Renal Tumor: Case Report. South. Med. J. 2004, 97, 316–318. [Google Scholar] [CrossRef] [PubMed]
  12. Dhanani, N.N.; Jones, D.M.; Grossman, H.B. Medical management of renal actinomycosis. J. Urol. 2004, 171, 2373–2374. [Google Scholar] [CrossRef] [PubMed]
  13. Rubio Tortosa, I.; Sanchez Sanchis, M.; Coronel Sánchez, B.; Garcia Serrado, D.; Garcia Torrelles, M.; Vergés Prosper, A.; San Juan De La Orden, C. Actinomicosis ureteral: A propósito de un caso. Arch. Españoles. Urol. 2005, 58, 351–353. [Google Scholar] [CrossRef] [PubMed]
  14. Gidwami, A.L.; Connolly, D.; Khan, A.; Kemohan, R.; Brown, M.; Kenny, B. Renal, colonic and retroperitoneal actinomycosis—A case report. West Afr. J. Med. 2005, 24, 343–345. [Google Scholar] [CrossRef]
  15. Sallami, S.; Nouira, Y.; Hmidi, M.; Mekni, A.; Hendaoui, L. Pseudotumoral Renal Actinomycosis: A Case Report. Int. J. Urol. 2006, 13, 803–804. [Google Scholar] [CrossRef]
  16. Jalón Monzón, A.; Álvarez Múgica, M.; Seco Navedo, M.Á.; Fernández Gómez, J.M.; Bulnes Vázquez, V.; González Álvarez, R.C.; Gómez, F.J.; Sejas, F.J. A new form of presentation of renal actinomycosis: Renal tumor with retroperitoneal bleeding. Arch. Esp. Urol. 2006, 59, 756–759. Available online: https://www.redalyc.org/articulo.oa?id=181013928018 (accessed on 20 December 2024). [CrossRef]
  17. Yenarkarn, P.; Thoeni, R.F.; Hanks, D. Actinomycosis of left kidney with sinus tracts. Radiology 2007, 244, 309–313. [Google Scholar] [CrossRef]
  18. Efthimiou, I.; Mamoulakis, C.; Petraki, K.; Zorzos, I. Renal actinomycosis presenting as a suppurated solitary cyst. Indian J. Urol. 2008, 24, 416–418. [Google Scholar] [CrossRef]
  19. Lin, Y.-H.; Chen, H.-W.; Chuang, C.-K.; Ng, K.-F.; Wang, H.-H. Renal Actinomycosis Presented as Emphysematous Pyelonephritis: A Case Report. JTUA 2009, 20, 181–183. [Google Scholar]
  20. Baburaj, P.; Antony, T.; Madhu, C.S.; Harikrishnan, B.L. A rare case of Pyrexia of Unknown Origin due to Renal Actinomycosis. Kerala Med. J. 2009, 2, 91–92. [Google Scholar] [CrossRef]
  21. Manasanch, E.E.; Grivas, P.D.; Walter, O.; Davaro, R. Kidney actinomycosis, a rare diagnosis that can mimic renal cell carcinoma: A case report and review of the literature. Infect. Dis. Clin. Pract. 2012, 20, 362–364. [Google Scholar] [CrossRef]
  22. Lin, C.D.; Tai, H.C.; Wang, C.C.; Yu, C.T.; Chang, S.J.; Hsieh, C.H.; Shei-Dei Yang, S. Renal actinomycosis-An unusual cause of a renal abscess. Urol. Sci. 2012, 23, 129–132. [Google Scholar] [CrossRef]
  23. Pourmand, M.R.; Dehghani, S.; Hadjati, M.; Kosari, F.; Pourmand, G. Renal Actinomycosis in Presence of Renal Stones in a Patient with End Stage Renal Disease. J. Med. Bacteriol. 2012, 1, 62–65. [Google Scholar]
  24. Herbland, A.; Leloup, M.; Levrat, Q.; Guillaume, F.; Verrier, V.; Bouillard, P.; Landois, T.; Ouaki, C.F.; Lesieur, O. Fulminant course of unilateral emphysematous pyelonephritis revealing a renal actinomycosis caused by Actinomyces meyeri, an unknown cause of septic shock. J. Intensive Care 2014, 2, 42. [Google Scholar] [CrossRef]
  25. Agrawal, P.; Vaiphei, K. Renal actinomycosis. BMJ Case Rep. 2014, 2014, 1–2. [Google Scholar] [CrossRef] [PubMed]
  26. Smid, M.C.; Bhardwaj, N.R.; Di Giovanni, L.M.; Eggener, S.; Della Torre, M. Renal hemorrhagic actinomycotic abscess in pregnancy. Infect. Dis. Rep. 2014, 6, 1–2. [Google Scholar] [CrossRef]
  27. Gulwani, H.V. Xanthogranulomatous pyelonephritis with colesional actinomycosis in a 63-year-old man. Indian J. Urol. 2015, 31, 144–145. [Google Scholar] [CrossRef]
  28. Niknejad, N.; Moradi, B.; Niknezhad, N.; Safaei, M.; Nili, F. Renal actinomycosis, a rare diagnosis which can clinically mimic a malignancy, case report and review of the literature. Arch. Pediatr. Infect. Dis. 2018, 6, 4–8. [Google Scholar] [CrossRef]
  29. Diab, C.; Almarzouq, A.; Ajise, O.; Barkati, S.; Tchervenkov, J.; Andonian, S. Renal actinomycosis presenting as uro-cutaneous fistula. Urol. Case Rep. 2020, 28, 101054. [Google Scholar] [CrossRef]
  30. Heo, S.H.; Shin, S.S.; Kim, J.W.; Lim, H.S.; Seon, H.J.; Jung, S.I.; Jeong, Y.Y.; Kang, H.K. Imaging of actinomycosis in various organs: A comprehensive review. Radiographics 2014, 34, 19–33. [Google Scholar] [CrossRef]
  31. Shanbhogue, K.P.; Ramani, N.; Surabhi, V.R.; Balasubramanya, R.; Prasad, S.R. Tumefactive Nonneoplastic Proliferative Pseudotumors of the Kidneys and Urinary Tract: CT and MRI Findings with Histopathologic Correlation. Radiographics 2023, 43, e230071. [Google Scholar] [CrossRef] [PubMed]
  32. Williams, S.K.; Denton, K.J.; Minervini, A.; Oxley, J.; Khastigir, J.; Timoney, A.G.; Keeley, F.X., Jr. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J. Endourol. 2008, 22, 71–76. [Google Scholar] [CrossRef] [PubMed]
  33. Scotland, K.B.; Kleinmann, N.; Cason, D.; Ehdaie, B. Ureteroscopic biopsy of upper tract urothelial carcinoma: A systematic review. J Endourol. 2013, 27, 560–567. [Google Scholar] [CrossRef]
  34. Roupret, M.; Seisen, T.; Birtle, A.J.; Capoun, O.; Compérat, E.M.; Dominguez-Escrig, J.; Andersson, I.G.; Liedberg, F.; Mariappan, P.; Mostafid, A.H.; et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur. Urol. 2023, 84, 49–64. [Google Scholar] [CrossRef]
  35. Sullivan, D.C.; Chapman, S.W. Bacteria that masquerade as fungi: Actinomycosis/nocardia. Proc. Am. Thorac. Soc. 2010, 7, 216–221. [Google Scholar] [CrossRef]
  36. Kolbert, C.P.; Persing, D.H. Ribosomal DNA sequencing as a tool for identification of bacterial pathogens. Curr. Opin. Microbiol. 1999, 2, 299–305. [Google Scholar] [CrossRef]
  37. Lane, D.J. 16S/23S rRNA sequencing. In Nucleic Acid Techniques in Bacterial Systematics; Stackebrandt, E., Goodfellow, M., Eds.; John Wiley & Sons: Chichester, UK, 1991; pp. 115–175. [Google Scholar]
  38. Wade, W.G.; Könönen, E. Propionibacterium, Lactobacillus, Actinomyces, and other non-spore-forming anaerobic gram-positive rods. In Manual of Clinical Microbiology, 10th ed.; Versalovic, J., Carroll, K.C., Funke, G., Jorgensen, J.H., Landry, M.L., Warnock, D.W., Eds.; ASM Press: Washington, DC, USA, 2011; pp. 817–833. [Google Scholar]
  39. Smith, A.J.; Hall, V.; Thakker, B.; Gemmell, C.G. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J. Antimicrob. Chemother. 2005, 56, 407–409. [Google Scholar] [CrossRef]
  40. Goldstein, E.J.C.; Citron, D.M.; Merriam, C.V.; Warren, Y.A.; Tyrrell, K.L.; Fernandez, H.T.; Bryskier, A. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli. Antimicrob. Agents Chemother. 2005, 49, 408–413. [Google Scholar] [CrossRef]
Figure 1. (A) Right kidney with significant cortical thinning, accompanied by ureterohydronephrosis (red arrow), suggesting a possible chronic obstruction of the urinary tract; (B) Pelvic mass measuring 46 × 25 mm, seemingly originating in the lumen of the right ureter, with infiltration into its distal third (red circle), a finding that raises a differential diagnosis between a urothelial tumor and a severe inflammatory infectious process.
Figure 1. (A) Right kidney with significant cortical thinning, accompanied by ureterohydronephrosis (red arrow), suggesting a possible chronic obstruction of the urinary tract; (B) Pelvic mass measuring 46 × 25 mm, seemingly originating in the lumen of the right ureter, with infiltration into its distal third (red circle), a finding that raises a differential diagnosis between a urothelial tumor and a severe inflammatory infectious process.
Microorganisms 13 01033 g001
Figure 2. Ureteroscopy: Endoscopically, a guide wire (red arrow) and a tumor dependent on the lumen of the right ureter in the lower third with obstruction (green arrow) are observed. Additionally, blood clots surrounding the tumor are visualized (blue arrows). Upon passage of the guide wire, pyuria is noted due to the tumor causing complete obstruction, resulting in a foggy appearance.
Figure 2. Ureteroscopy: Endoscopically, a guide wire (red arrow) and a tumor dependent on the lumen of the right ureter in the lower third with obstruction (green arrow) are observed. Additionally, blood clots surrounding the tumor are visualized (blue arrows). Upon passage of the guide wire, pyuria is noted due to the tumor causing complete obstruction, resulting in a foggy appearance.
Microorganisms 13 01033 g002
Figure 3. (A) Product of radical right nephroureterectomy with bladder cuff (290 g): calyces and renal pelvis with the presence of abundant inflammatory exudates and ureter tumor in the lower third (red arrow) with a report of intraluminal fibrosis without infiltrating the wall, (B) Macroscopic: renal abscess (green arrow).
Figure 3. (A) Product of radical right nephroureterectomy with bladder cuff (290 g): calyces and renal pelvis with the presence of abundant inflammatory exudates and ureter tumor in the lower third (red arrow) with a report of intraluminal fibrosis without infiltrating the wall, (B) Macroscopic: renal abscess (green arrow).
Microorganisms 13 01033 g003
Figure 4. Microscopic renal abscess: hematoxylin-eosin staining at 40×, where leukocyte infiltration is observed in the interface with filamentous bacillary structures arranged in a radial and disordered manner and a deposit of eosinophilic material.
Figure 4. Microscopic renal abscess: hematoxylin-eosin staining at 40×, where leukocyte infiltration is observed in the interface with filamentous bacillary structures arranged in a radial and disordered manner and a deposit of eosinophilic material.
Microorganisms 13 01033 g004
Table 1. Reported cases of actinomycosis with urinary tract involvement.
Table 1. Reported cases of actinomycosis with urinary tract involvement.
GenderAge (Years)Clinical
Presentation
Imaging FindingsDiagnostic
Method
SpeciesRisk FactorsTreatmentOutcomeReference
Female19Renal tumor with duodenal fistulaUS: Extensive tumor mass affecting the right kidneyHistopathologyNot identifiedDMRadical
nephrectomy
Alive[6]
Male 45Renal tumorUS: 7-cm solid mass in the upper pole of the right kidney with less echogenicity than the renal cortex and with a multinodular internal pattern + poorly delimited subcutaneous lesion at the thoracic level
CT: enlarged right kidney or with
heterogeneous contrast enhancement and edema in the fascia, renal hilum, muscles, retroperitoneum and pleura
HistopathologyNot identifiedNoneIV penicillin for two months and then orally for at least 4 monthsAlive[7]
Male41Renal tumorUS: heterogeneous left renal mass that bulges around the contour and compromises the renal sinus and parenchyma.
CT: Tissue mass infiltrating the left kidney with contrast enhancement
+ enlarged psoas muscle or with
multiple ring-shaped enhancements + small focal hypodensity in the liver
HistopathologyNot identifiedDMAbscess drainage and a high dose of oral penicillinAlive[8]
Male52Renal tumorUS: left-sided renal mass
CT: 4 cm mass in the upper pole region of the left kidney with an irregularly shaped radiolucent middle area
HistopathologyNot identifiedNoneNephrectomy
and oral amoxicillin for 3 months
Alive[9]
Male16Renal tumorCT: renal mass in the upper right pole + mass in the left lobe of the liver + multiple pulmonary nodulesHistopathology +
Positive abscess culture
Actinomyces israelii + Actinobacillus actinomycetemycomitansNoneIV penicillin
for two weeks, followed by oral doxycycline for 6 months
Alive[10]
Male68Renal tumorUS: Hypoechoic solid mass of the
right kidney
CT: Enlarged right kidney with a mass with little enhancement with contrast medium
MRI: Renal tumor of hypo to isointense (T1) and hypointense (T2)
HistopathologyNot identifiedOral
infections
NephrectomyAlive[11]
Male64Renal tumorCT: heterogeneous mass with enhancement in the right flank containing air-fluid levels and an inflammatory reaction affecting the right colon and psoas muscleHistopathology
Not identified IV penicillin for 8 weeks followed by doxycycline + oral ciprofloxacin for 4 monthsAlive[12]
Male66Right ureter tumorUS: grade II ureteric opyelo-calicectasis of the right kidney
CT: Hydronephrotic atrophy of the right kidney, with no intraureteral endoluminal images visible
HistopathologyNot identifiedDMRight radical nephroureterectomyAlive[13]
Male41Renal tumorCT: large mass compatible with a large locally advanced left hypernephroma, with invasion of the left psoas and descending colonHistopathologyNot identifiedNoneNephrectomy Alive[14]
Female 25Renal tumorCT: Right renal solid mass that enhances with contrast with central liquefaction areas and invades the liver, alveolar infiltratesHistopathologyNot identifiedPregnancyNephrectomy
and oral penicillin for 2 months
Alive[15]
Female27Renal tumor with retroperitoneal bleedingUS and CT: Right renal mass with retroperitoneal bleedingHistopathologyNot identifiedNoneNephrectomy Alive[16]
Male39Chronic kidney infection
CT: Enlargement of the left kidney due to an infiltrative process with
enhancement + wall of the descending colon with increased thickness and enhancement + sinus tracts extending from the colon to the left iliopsoas muscle and the muscles of the abdominal wall
HistopathologyNot identifiedNoneNephrectomy +
segmental resection of the descending colon
Oral penicillin for 6 months
Alive[17]
Female50Kidney cyst
US: 8 × 8 cm left renal mass with a central fluid portion and a thick surrounding wall
CT: Enlarged left kidney with a well-delineated 5 × 9 cm cystic lesion of homogeneous content of 0–3 HU surrounded by a thickened outer wall without contrast enhancement.
Positive culture of purulent dischargeActinomyces
israelii
NoneNephrectomy
and oral amoxicillin for 3 months
Alive[18]
Female42Septic shock caused by Emphysematous pyelonephritisCT: striation of perirenal fat, calculus at the right ureteropelvic junction with formation of air and subcapsular fluid in the right kidney, mild right pleural effusionHistopathologyNot identifiedDM
Kidney
stones
Nephrectomy and
oral penicillin
Alive[19]
Male55Renal tumorUS: Heterogeneous mass in the upper pole of the left kidney
CT: Mass in the upper pole of the left kidney with thickening of the renal fascia
MRI: Hypointense mass on T1 and T2
HistopathologyNot identifiedNoneNephrectomy and
oral penicillin for 8
weeks
Alive[20]
Female80Renal tumorMRI: central hyperintense lesion with a surrounding isointense mass on T2-weighted images, suggestive of central necrotizing tumor
CT: exophytic renal mass with extension contiguous to the diaphragm, pleural space and lower right lobe
Positive culture of purulent fluidActinomyces
gerencseriae
Renal
carcinoma
Oral penicillin G for 3 weeks and then amoxicillin for 6 months.Alive[21]
Female59Pyonephrosis
US: cystic renal mass with an irregular solid border
CT: enlarged right kidney infiltrated with multiple cystic lesions with hypodense content
Positive blood culture +
Histopathology
Not identifiedDM
ESRD
Nephrectomy and
Penicillin for 4
weeks
Alive[22]
Male56AsymptomaticUS: multiple stones in both kidneysHistopathologyNot identifiedNephrolithiasis with
ureteral
catheterization
Right nephrectomy and
doxycycline for 4 weeks
Alive[23]
Female75Septic shock caused by Emphysematous pyelonephritisCT: pyonephrosis of the right kidney, pneumaturia in the collecting system, cyst in the lower pole, dilated pelvicalyceal cavities
CT: persistent posterior abscess of the right kidney with infiltration of the perinephric space
Positive urine cultureActimomyces meyeriNoneOpen stenting of the right ureter with drainage of
Pyuria + percutaneous drainage of the abscess
Amoxicillin for 3 months
Alive[24]
Male52Septic shock with bilateral necrotizing papillitisUS: loss of corticomedullary differentiation and increased renal echogenicity.
CT: enlarged kidneys with reduced nephrogenic density and compact pyelocaliceal system.
HistopathologyNot identifiedDMCefotaxime and azithromycin, empiricallyDeceased[25]
Female20Renal tumorUS: Hemorrhagic mass in the right renal subcapsular area extending to the right diaphragm
MRI: Heterogeneous mass in the right kidney extending to the edge of the liver and mild hydronephrosis, splenomegaly
HistopathologyNot identifiedPregnancyResection of retroperitoneal mass +
partial nephretomy
IV piperacillin
/Tazobactam and subsequently amoxicillin/clavulanate for 6 months
Alive[26]
Male63Xanthogranulomatous pyelonephritisCT: Diffuse Xanthogranulomatous pyelonephritis in the left kidney with extension of inflammation to the pararenal tissuesHistopathologyNot identifiedNoneNot availableNot available[27]
Male8Renal tumor + Xanthogranulomatous pyelonephritisUS: solid cystic mass with extension to perinephric adipose tissue
CT: enlargement of the right kidney with thickening of Gerota’s fascia and heterogeneous mass with cystic component in the upper pole of the right kidney
HistopathologyNot identifiedNoneRight nephrectomy
and amoxicillin for 4 months
Alive[28]
Male 36Xanthogranulomatous pyelonephritisCT: left Xanthogranulomatous pyelonephritis with a staghorn calculus and a urocutaneous fistulaHistopathology and + Positive culture of purulent dischargeActinomyces odontolyticus Proteus mirabilisKidney stonesRadical left nephrectomy
IV ertapenem for 6 weeks
Alive[29]
Female33Right ureter
tumor
CT: Right kidney with decreased cortical thickness associated with ureterohydronephrosis + Pelvic tumor with apparent origin in the lumen of the right ureter with infiltration into the distal third + liver lesion with liquid and solid componentsHistopathologyNot identifiedDMNephrectomy and
Amoxicillin for 6 months
Alive**
US = ultrasound; CT = computed tomography; MRI = magnetic resonance imaging; DM = Diabetes Mellitus; ESRD = end-stage renal disease; IV = intravenous.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Meza-Meneses, P.A.; Becerra, R.P.; Sainz, G.G.; Ortiz, L.T.; Correa, A.M.; Soriano, A.R.P.; Santiago González, R.M.A.; Corral, A.D.; Valdez, O.V.; Morales, G.A.; et al. Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review. Microorganisms 2025, 13, 1033. https://doi.org/10.3390/microorganisms13051033

AMA Style

Meza-Meneses PA, Becerra RP, Sainz GG, Ortiz LT, Correa AM, Soriano ARP, Santiago González RMA, Corral AD, Valdez OV, Morales GA, et al. Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review. Microorganisms. 2025; 13(5):1033. https://doi.org/10.3390/microorganisms13051033

Chicago/Turabian Style

Meza-Meneses, Patricia A., Rodrigo Pérez Becerra, Gerardo Garza Sainz, Luis Trujillo Ortiz, Adrián Martinez Correa, Alan Rodrigo Pérez Soriano, Ruben Miguel Angel Santiago González, Aarón Delgado Corral, Omar Vieyra Valdez, Genaro Argüelles Morales, and et al. 2025. "Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review" Microorganisms 13, no. 5: 1033. https://doi.org/10.3390/microorganisms13051033

APA Style

Meza-Meneses, P. A., Becerra, R. P., Sainz, G. G., Ortiz, L. T., Correa, A. M., Soriano, A. R. P., Santiago González, R. M. A., Corral, A. D., Valdez, O. V., Morales, G. A., Díaz, M. A. T., Luna, A. S., Castro-Fuentes, C. A., & Osornio Sánchez, V. (2025). Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review. Microorganisms, 13(5), 1033. https://doi.org/10.3390/microorganisms13051033

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop